CD8A and neoplasm: Chang Liu reported that CD8+ T cell-restricted NRP1 deletion exhibited substantially enhanced protection from tumor rechallenge and sensitivity to anti-PD1 immunotherapy, making NRP1 a unique immune memory checkpoint [105].